IDiyas

For the Inventor, By the Inventor

Nagaokakyo, Japan

Hiroshi Enomoto

USPTO Granted Patents = 35

Average Co-Inventor Count = 6.1

ph-index = 8

Forward Citations = 334(Granted Patents)


Location History:

  • Minami Kyoto, JA (1977)
  • Kyoto, JA (1977 - 1978)
  • Kameoka, JP (1978)
  • Nagaokakao, JP (1982)
  • Nagaokakyo, JP (1980 - 1987)
  • Nagoakakyo, JP (1985 - 1987)
  • Magaokakyo, JP (1987)
  • Kyoto, JP (1979 - 1988)

Company Filing History:

goldMedal33 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents
silverMedal2 out of 614 
 
Mitsubishi Chemical Industries Limited
 patents
bronzeMedal1 out of 190 
 
Takara Shuzo Co., Inc.
 patents
4. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1977-1988

Loading Chart...
35 patents (USPTO):Explore Patents
1. 4720506 - Immunomodulating agent (1988-01-19),
2. 4711898 - 4-quinolone derivatives having anti-inflammatory, anti-allergic, (1987-12-08),
3. 4659734 - Olinecarboxylic acid derivatives (1987-04-21),
4. 4657907 - Low dosage compositions of finely pulverized (1987-04-14),
5. 4642307 - 1-phenoxy-3-(4-phenylpiperidino)-2-propand having both alpha- and (1987-02-10),
6. 4594345 - Methylflavone-8-carboxylates (1986-06-10),
7. 4554289 - OF4949 (1985-11-19),
8. 4533668 - Antihyperglycemic moranoline derivatives (1985-08-06),
9. 4532238 - Finely pulverized 2,4-diamino-6-(2,5-dichloro-phenyl)-1,3,5-triazine and (1985-07-30),
10. 4526894 - Pharmaceutically active 4-hydroxy-3-benzoyl-2-quinolone derivatives (1985-07-02),
11. 4487770 - Treatment of diseases of the liver, kidney, colon and rectum (1984-12-11),
12. 4439448 - Glutamine derivatives (1984-03-27),
13. 4435397 - Carbamylpiperazine compounds (1984-03-06),
14. 4415570 - Nicotinic acid derivatives (1983-11-15),
15. 4402948 - Steroid glycoside compounds and methods of use (1983-09-06),

Title: Hiroshi Enomoto: A Leading Innovator in Immunomodulation and Anti-Inflammatory Research

Introduction

Hiroshi Enomoto is an accomplished inventor based in Nagaokakyo, Japan, with an impressive portfolio of 35 patents. His work predominantly focuses on the development of pharmaceutical compounds that exhibit significant immunomodulating and anti-inflammatory properties.

Latest Patents

Among his latest innovations are the immunomodulating agents derived from phenylacetic acid and various 4-quinolone derivatives. The phenylacetic acid derivatives, as outlined in his patent, possess immunomodulating activity, making them valuable in treating a range of health conditions. In addition, his work on 4-quinolone derivatives highlights their utility in anti-inflammatory, anti-allergenic, antitussive, expectorant, and antithrombotic applications, alongside descriptions of pharmaceutical compositions that utilize these compounds.

Career Highlights

Hiroshi Enomoto has made significant contributions through his tenure at esteemed companies such as Nippon Shinyaku Company, Ltd. and Mitsubishi Chemical Industries Limited. His work at these organizations has allowed him to further his research and patent filings, establishing him as a prominent figure in the pharmaceutical industry.

Collaborations

Throughout his career, Hiroshi has collaborated with notable colleagues, including Yoshiaki Aoyagi and Yoshiaki Yoshikuni. These partnerships have been instrumental in fostering innovative research and enhancing the impact of their collective work on drug development.

Conclusion

Hiroshi Enomoto's dedication to innovation in the field of pharmaceuticals is reflected in his substantial patent portfolio and his ongoing research efforts. His contributions in immunomodulation and anti-inflammatory therapies continue to shape the landscape of modern medicine, underscoring the importance of innovation in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…